Patents by Inventor Shelley Q. Wang

Shelley Q. Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11857641
    Abstract: Described herein are methods and compositions for treating MPS I (Hurler/Hurler-Scheie/Scheie Syndrome) by administering to the subject a composition comprising a iduronidase (IDUA) polynucleotide. In one aspect, provided is a method of reducing, delaying and/or eliminating one or more of the need for additional treatment procedures, the onset, progression and/or severity of symptoms in a subject with MPS I, by administering to the subject a composition comprising a iduronidase (IDUA) polynucleotide.
    Type: Grant
    Filed: August 7, 2019
    Date of Patent: January 2, 2024
    Assignee: Sangamo Therapeutics, Inc.
    Inventors: Dale Ando, Cheryl Wong Po Foo, Sagar A. Vaidya, Shelley Q. Wang
  • Publication number: 20200246486
    Abstract: Described herein are methods and compositions for treating MPS I (Hurler) disease.
    Type: Application
    Filed: August 7, 2019
    Publication date: August 6, 2020
    Inventors: Dale Ando, Cheryl Wong Po Foo, Sagar A. Vaidya, Shelley Q. Wang
  • Publication number: 20200071743
    Abstract: Described herein are enzymatic assays for assessing in vivo therapy of MPSII (Hunter) or MPSI (Hurler) subjects.
    Type: Application
    Filed: August 7, 2019
    Publication date: March 5, 2020
    Inventors: Liching Cao, Yonghua Pan, Shelley Q. Wang
  • Publication number: 20200063160
    Abstract: Described herein are methods and compositions for treating MPSII (Hunter) disease.
    Type: Application
    Filed: August 7, 2019
    Publication date: February 27, 2020
    Inventors: Dale Ando, Cheryl Wong Po Foo, Sagar A. Vaidya, Shelley Q. Wang